- Overview:
- This study will evaluate the safety and effectiveness of insulin Lyumjev and the 780G System within a home setting, of either adult or pediatric individuals with Type 1 diabetes.
- Staus:
- Enrolling
- Clinical Description:
- This study will evaluate the safety and effectiveness of using insulin Lyumjev and 780G System in Type 1 adult and pediatric subjects in a home setting. The 780 pump is a hybrid closed loop system with an extended infusion set and reservoir.
- Target Age/Sex:
- 7 - 17 Years Old, Male & Female
- Benefits:
- Participants will receive at no cost: use of study pump with pump supplies and Lyumjev insulin during the study period with study materials and study-specific procedures.
- Study Length:
- Approximately 4 Months
- Link:
- ClinicalTrials.gov
